Catalin Danaı̈la

Statistics

Publications

Citations

H-Index

Active since

2002

Affiliations

Grigore T. Popa University of Medicine and Pharmacy(Current)

Institutul Regional de Oncologie

Catalin Danaı̈la is an author at Grigore T. Popa University of Medicine and Pharmacy specializing in hematology, medicine, and b7 family immunoregulatory ligands.

Publications per year

2002–2022

Publications

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors

Xavier Thomas, Quoc‐Hung Le, Catalin Danaı̈la et al. · Leukemia Research · 2002 · 21 citations

Medicine, Hematology, Oncology +16

The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression

Ion Antohe, Mariana Pavel-Tanasă, Angela Dǎscǎlescu et al. · Immunobiology · 2020 · 15 citations

Life Sciences, Hematology, Immunology +16

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles

Ion Antohe, Angela Dǎscǎlescu, Catalin Danaı̈la et al. · Frontiers in Oncology · 2020 · 14 citations · Full text

Medicine, Hematology, Immunology +16

1–4 of 4